KR890005041A - 7-디페닐 메틸렌비사이클로헵탄 또는 7-디페닐메틸렌비사이클로헵텐 유도체를 함유한 약제학적 제제, 약제로서의 이들 화합물의 용도, 및 신규한 7-디페닐메틸렌비사이클로 헵탄 및 7-디페닐메틸렌비사이클로 헵텐 및 이들의 제조방법 - Google Patents

7-디페닐 메틸렌비사이클로헵탄 또는 7-디페닐메틸렌비사이클로헵텐 유도체를 함유한 약제학적 제제, 약제로서의 이들 화합물의 용도, 및 신규한 7-디페닐메틸렌비사이클로 헵탄 및 7-디페닐메틸렌비사이클로 헵텐 및 이들의 제조방법 Download PDF

Info

Publication number
KR890005041A
KR890005041A KR1019880012236A KR880012236A KR890005041A KR 890005041 A KR890005041 A KR 890005041A KR 1019880012236 A KR1019880012236 A KR 1019880012236A KR 880012236 A KR880012236 A KR 880012236A KR 890005041 A KR890005041 A KR 890005041A
Authority
KR
South Korea
Prior art keywords
formula
hydrogen
alkyl
compound
group
Prior art date
Application number
KR1019880012236A
Other languages
English (en)
Inventor
지겔 헤르베르트
그란제 에르놀드
Original Assignee
하인리히 벡커
훽스트 아크티엔게젤샤프트
베른하르트 벡크
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 하인리히 벡커, 훽스트 아크티엔게젤샤프트, 베른하르트 벡크 filed Critical 하인리히 벡커
Publication of KR890005041A publication Critical patent/KR890005041A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Furan Compounds (AREA)

Abstract

내용 없음

Description

7-디페닐 메틸렌비사이클로헵탄 또는 7-디페닐메틸렌비사이클로헵텐 유도체를 함유한 약제학적 제제, 약제로서의 이들 화합물의 용도, 및 신규한 7-디페닐메틸렌비사이클로 헵탄 및 7-디페닐메틸렌비사이클로 헵텐 및 이들의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (8)

  1. 일반식(I)의 7-디페닐메틸렌비사이클로 헵탄 또는 -헵텐, 또는 B가 염기성 치환체일 경우 이들의 생리학적으로 허용되는 산부가염을 함유하는 약제학적 제제.
    상기식에서, A는 단일결합 또는 이중결합이고, B는의 카복스아미드그룹 또는 일반식의 메틸렌아미노그룹(여기에서, R5및 R6은 동일하거나 상이하며, 수소 또는 C1-C4-알킬이거나, 질소원자와 함께 모르폴린 또는 피페라진 환, 또는 4-위치에서 C1-C4-알킬로 치환된 피페라진환을 형성한다)이거나, -OH, -CN2H -CO2-(C1-C4)-알킬 또는알킬이며, R1은 수소, 염소, C1-C4-알킬이거나, B와 함께, 옥심그룹(=N-OH) 또는 이중결합으로 결합된 산소(=O)를 나타내고, R2은 수소, 또는 B와 함께 디카복실산 무수물또는 디카복스이미드를 나타내며, R3및 R4은 동일하거나 상이하고, 수소, 할로겐, (C1-C4)-알킬, (C1-C4)-알콕시, 트리플루오로메틸, 하이드록실, 아미노, (C1-C4)-알킬아미노 또는 디-(C1-C4)-알킬아미노이다.
  2. 약제로서의 일반식(I)의 화합물 또는 이들의 생리학적으로 허용되는 염의 용도.
  3. 약제를 제조하기 위한 일반식(I)의 화합물 또는 이들의 생리학적으로 허용되는 염의 용도.
  4. 일반식(I)의 화합물 또는 이들의 생리학적으로 허용되는 산부가염을 함유하는 과유지질혈증 치료제.
  5. 제1항에 있어서, A가 단일결합이고, B가 -COWH, -CN, -CH2OH 또는 -OH그룹이며, R1이 수소 또는, B와 함께 이중결합으로 결합된 산소(=O) 또는 옥심그룹(=N-OH)을 나타내고, R2이 수소이며, R3및 R4가 수소 또는 할로겐인 일반식(I)의 화합물을 활성성분으로서 함유하는 약제학적 제제.
  6. 일반식(Ia)의 7-디페닐메틸렌비사이클로 헵탄 및 7-디페닐 메틸렌 비사이클로헵텐, 및 이들의 생리학적으로 허용되는 산부가염.
    상기 식에서, A는 단일결합 또는 이중결합이고, B는 일반식의 카복스아미드그룹 또는 일반식의 메틸렌아미노그룹(여기에서, R5및 R6은 동일하거나 상이하며, 수소 또는 C1-C4-알킬이거나, 질소원자와 함께 모르폴린 또는 피페라진 환, 또는 4-위치에서 C1-C4-알킬로 치환된 피페라진환을 형성한다)이고, R1은 수소, 염소, C1-C4-알킬이거나, B와 함께, 옥심그룹(=N-OH) 을 나타내며, R2은 수소이고, R3및 R4은 동일하거나 상이하고, 수소, 할로겐, (C1-C4)-알킬, (C1-C4)-알콕시, 트리플루오로메틸, 하이드록실, 아미노, (C1-C4)-알킬아미노 또는 디-(C1-C4)-알킬아미노이다.
  7. 제6항에 있어서, A가 단일결합이고, B와 R1이 함께 옥심그룹을 형성하며, R3및 R4가 수소 또는 염소인 일반식(Ia)의 화합물.
  8. (A) 일반식(Ib)의 비사이클로 헵탄-또는 비사이클로 헵탄카복실산을 염소화제를 사용하여 상응하는 산클로라이드로 전환시킨 다음, 이를 아민과 반응시켜 일반식(Ia)의 화합물을 수득하고, 필요할 경우, 생성된 카복스아미드 유도체를 환원시켜 B가그룹을 나타내는 일반식(Ia)를 형성하거나, (B) 일반식(Ic)의 케톤을 하이드록실아민 하이드로클로라이드와 반응시켜 일반식(Ia)의 화합물을 수득하고, 필요할 경우, A가 이중결합으로 나타나는 일반식(Ia0의 생성화합물 내의 이중결합을 수소화시켜, 필요할 경우, 일반식(Ia)의 화합물을 생리학적으로 허용되는 산부가염으로 전환시킴으로 하여, 일반식(Ia)의 화합물을 제조하는 방법.
    상기 식에서, A, B, R2, R3및 R4은 제6항의 일반식(Ia)에서 정의한 바와 같고, R1은 (A)의 경우 수소 또는 염소이며, (B)의 경우 B와 함께 =NOH 그룹을 형성한다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019880012236A 1987-09-23 1988-09-22 7-디페닐 메틸렌비사이클로헵탄 또는 7-디페닐메틸렌비사이클로헵텐 유도체를 함유한 약제학적 제제, 약제로서의 이들 화합물의 용도, 및 신규한 7-디페닐메틸렌비사이클로 헵탄 및 7-디페닐메틸렌비사이클로 헵텐 및 이들의 제조방법 KR890005041A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3731913.2 1987-09-23
DE19873731913 DE3731913A1 (de) 1987-09-23 1987-09-23 Pharmazeutische praeparate enthaltend ein 7-diphenylmethylenbicycloheptan- oder 7-diphenylmethylenbicyclohepten-derivat, die verwendung dieser verbindungen als arzneimittel sowie neue 7-diphenylmethylenbicycloheptane und 7-diphenylmethylenbicloheptene und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
KR890005041A true KR890005041A (ko) 1989-05-11

Family

ID=6336607

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880012236A KR890005041A (ko) 1987-09-23 1988-09-22 7-디페닐 메틸렌비사이클로헵탄 또는 7-디페닐메틸렌비사이클로헵텐 유도체를 함유한 약제학적 제제, 약제로서의 이들 화합물의 용도, 및 신규한 7-디페닐메틸렌비사이클로 헵탄 및 7-디페닐메틸렌비사이클로 헵텐 및 이들의 제조방법

Country Status (13)

Country Link
US (1) US5141937A (ko)
EP (1) EP0308839A3 (ko)
JP (1) JPH01113351A (ko)
KR (1) KR890005041A (ko)
AU (1) AU612177B2 (ko)
DE (1) DE3731913A1 (ko)
DK (1) DK527388A (ko)
FI (1) FI884343A (ko)
HU (2) HU200991B (ko)
IL (1) IL87818A0 (ko)
NO (1) NO884207L (ko)
PT (1) PT88572B (ko)
ZA (1) ZA887047B (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0655053B1 (en) * 1992-06-19 1997-09-03 James Black Foundation Limited Bicyclooctane and bicycloheptane derivatives
MXPA06001094A (es) 2003-07-28 2006-04-11 Smithkline Beecham Corp Compuestos quimicos.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4550186A (en) * 1983-07-11 1985-10-29 Duke University Binuclear copper (II) carboxylates formed from amine-carboxyboranes
DE3410498A1 (de) * 1984-03-22 1985-10-03 Hoechst Ag, 6230 Frankfurt N-bicycloheptyl- und n-bicycloheptenyl-imidazole, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate

Also Published As

Publication number Publication date
AU612177B2 (en) 1991-07-04
IL87818A0 (en) 1989-03-31
HUT48199A (en) 1989-05-29
DK527388A (da) 1989-03-24
ZA887047B (en) 1989-06-28
JPH01113351A (ja) 1989-05-02
DK527388D0 (da) 1988-09-22
HU204431B (en) 1992-01-28
HU902054D0 (en) 1990-07-28
FI884343A0 (fi) 1988-09-21
EP0308839A2 (de) 1989-03-29
DE3731913A1 (de) 1989-04-06
EP0308839A3 (de) 1989-09-20
US5141937A (en) 1992-08-25
PT88572B (pt) 1992-11-30
AU2273088A (en) 1989-03-23
PT88572A (pt) 1988-10-01
NO884207L (no) 1989-03-28
NO884207D0 (no) 1988-09-22
HU200991B (en) 1990-09-28
FI884343A (fi) 1989-03-24

Similar Documents

Publication Publication Date Title
HUP0102102A2 (hu) Pirazolinszármazékok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
NO20061833L (no) Aerosolformulgering for inhalering, inneholdende anticholinergt middel
NO173139C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-aminopyrimidinonderivater
NO855355L (no) Fremgangsmaate for fremstilling av naftalenderivater.
ATE122668T1 (de) Diarylsubstituierte heterocyclische verbindung, ihre herstellung und arzneimittel und kosmetika daraus.
TNSN88096A1 (fr) Nouveau n-(1-alkyl-3-hydroxy-4-piperidyl)
ES2051834T3 (es) El uso de tetrahidrobenzeno(c,d)indol-6 carboxamidas para la preparacion de un medicamento para el tratamiento de la ansiedad.
NO20044810L (no) Farmasoytisk formulering med oyeblikkelig frigjoring
HUP0203884A2 (hu) Kristályos oximinoalkánsav-származékok és cukorbaj elleni alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
KR890005041A (ko) 7-디페닐 메틸렌비사이클로헵탄 또는 7-디페닐메틸렌비사이클로헵텐 유도체를 함유한 약제학적 제제, 약제로서의 이들 화합물의 용도, 및 신규한 7-디페닐메틸렌비사이클로 헵탄 및 7-디페닐메틸렌비사이클로 헵텐 및 이들의 제조방법
NO882641D0 (no) Nye n-(4-piperidinyl)bisyklisk kondensert 2-imidazilaminderivater.
ES475533A1 (es) Un metodo para la preparacion de formas racemicas y optica- mente activas de 2-(4-difenilil)-n-(dimetilamino-alquil)pro-pionamida
GB1530074A (en) Rho-acetamidophenol derivatives the preparation thereof and the use of such derivatives as therapeutic agents
HUP0004701A2 (hu) Új dezloratadin sók, az ezeket tartalmazó gyógyászati készítmények és eljárás azok előállítására
GB1505525A (en) Pyridopyrimidines
ES8708213A1 (es) Un procedimiento para preparar un derivado de 1-benzhidril--4-cinamilpiperazina
GB1503626A (en) Substituted piperazine derivative its preparation and compositions containing it
US3128278A (en) Substituted l
HUP0001727A2 (hu) Új 1-aza-2-alkil-6-aril-cikloalkán-származékok, eljárás előállításukra és ezeket tartalmazó gyógyászati készítmények
US3287217A (en) Compositions and methods for stimulat- ing the central nervous system and in- creasing the blood pressure
RU2006103364A (ru) 2,4-бис (трифторэтокси) пиридиновое соединение и содержащее его лекарственное средство
GB1384523A (en) Oxime derivatives and their preparation
GB1377610A (en) 5-piperidine-4-spiro- oxazolidinones method for their preparation and applications thereof
ES487971A1 (es) Procedimiento para la preparacion de nuevos derivados de p-cloroacetofenona oxima con actividad analgesica
GB1467761A (en) Phenoxypropylamine derivatives and preparation thereof

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid